Eye Hospital, Wenzhou Medical College
Wenzhou, Zhejiang, 325027, China
NCT Number: NCT01021046
The purpose of this study is to study whether deep anterior lamellar keratoplasty (DALK) using acellular tissue will promote corneal graft survival in high risk patients.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Wenzhou, Zhejiang, 325027, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Deep anterior lamellar keratoplasty (DALK) using glycerin-cryopreserved corneal tissue
Other names: acellular tissue
Deep anterior lamellar keratoplasty (DALK) using fresh corneal tissue
Wenzhou Medical University
Other
Deep Anterior Lamellar Keratoplasty Using Acellular Corneal Tissue Promotes Corneal Allograft Survival in High Risk Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04855422
Behavior, Rejection, Psychology
The Bronx, New York, United States
View Trial DetailsNCT03575910
Behavior, Cardiovascular Diseases
Omaha, Nebraska, United States
View Trial DetailsNCT01140152
Behavior, Cellular Rejection
Los Angeles, California, United States
View Trial DetailsNCT05064462
Behavior, Bone Diseases
Paris, France
View Trial Details